MiR-26b suppresses tumor cell proliferation, migration and invasion by directly targeting COX-2 in lung cancer.

Abstract

Taken together, our results demonstrate that miR-26b could suppress lung cancer cells proliferation, migration and invasion by directly negative regulation of COX-2. MiR-26b could serve as a novel potential marker for NSCLC therapy.